Buono, A.; Mühlenhaus, A.; Schäfer, T.; Trieb, A.-K.; Schmeißer, J.; Koppe, F.; Münzel, T.; Anadol, R.; Gori, T.
QFR Predicts the Incidence of Long-Term Adverse Events in Patients with Suspected CAD: Feasibility and Reproducibility of the Method. J. Clin. Med. 2020, 9, 220.
https://doi.org/10.3390/jcm9010220
AMA Style
Buono A, Mühlenhaus A, Schäfer T, Trieb A-K, Schmeißer J, Koppe F, Münzel T, Anadol R, Gori T.
QFR Predicts the Incidence of Long-Term Adverse Events in Patients with Suspected CAD: Feasibility and Reproducibility of the Method. Journal of Clinical Medicine. 2020; 9(1):220.
https://doi.org/10.3390/jcm9010220
Chicago/Turabian Style
Buono, Andrea, Annika Mühlenhaus, Tabitha Schäfer, Ann-Kristin Trieb, Julian Schmeißer, Franziska Koppe, Thomas Münzel, Remzi Anadol, and Tommaso Gori.
2020. "QFR Predicts the Incidence of Long-Term Adverse Events in Patients with Suspected CAD: Feasibility and Reproducibility of the Method" Journal of Clinical Medicine 9, no. 1: 220.
https://doi.org/10.3390/jcm9010220
APA Style
Buono, A., Mühlenhaus, A., Schäfer, T., Trieb, A.-K., Schmeißer, J., Koppe, F., Münzel, T., Anadol, R., & Gori, T.
(2020). QFR Predicts the Incidence of Long-Term Adverse Events in Patients with Suspected CAD: Feasibility and Reproducibility of the Method. Journal of Clinical Medicine, 9(1), 220.
https://doi.org/10.3390/jcm9010220